+499.5%
MRNA vs FANG
+43.7%
+455.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FANG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.8% | -0.4% | -2.9% |
| 7D | +5.5% | +0.8% | +4.7% | +5.8% |
| 30D | +158.7% | +7.6% | +151.1% | +160.9% |
| 3M | +182.1% | -1.3% | +183.4% | +186.1% |
| 6M | +151.8% | +14.7% | +137.2% | +151.3% |
| YTD | +393.6% | +34.8% | +358.8% | +382.2% |
| 1Y | +499.5% | +42.9% | +456.5% | +478.2% |
| All | +499.5% | +43.7% | +455.7% | +478.2% |
Cumulative growth
Daily Returns
Daily percentage return beside FANG.
Daily Out/Under-Performance
Portfolio return minus FANG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FANG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FANG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling